The mir-675-5p regulates the progression and development of pancreatic cancer via the UBQLN1-ZEB1-mir200 axis

Oncotarget

Volumn 8, Issue 15, 2017, Pages 24978-24987

  Wang, Jue ^a   Zhang, Youli ^a   Wei, Hong ^a   Zhang, Xingxing ^a   Wu, Yan ^b   Gong, Aihua ^b   Xia, Yu ^a   Wang, Wenbing ^b   Xu, Min ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Mir 200; Mir 675; Pancreatic cancer progression; UBQLN1; ZEB1

Indexed keywords

CASPASE 3; GELATINASE A; GELATINASE B; MICRORNA; MICRORNA 200; MICRORNA 675 5P; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; AUTOPHAGY RELATED PROTEIN; CARRIER PROTEIN; CELL CYCLE PROTEIN; MIRN200 MICRORNA, HUMAN; MIRN675 MICRORNA, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UBQLN1 PROTEIN, HUMAN; ZEB1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SEQUENCE; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UBQLN1 GENE; DISEASE EXACERBATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AUTOPHAGY-RELATED PROTEINS; CARCINOMA, PANCREATIC DUCTAL; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; HUMANS; MICRORNAS; PANCREATIC NEOPLASMS; TRANSFECTION; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 85017555969     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.15330     Document Type: Article

References (27)

1. American Cancer Society. Cancer facts and figures 2016. Atlanta (GA): American Cancer Society; 2016
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J. Cancer statistics,2008. CA Cancer J Clin. 2008; 58:71-96
3. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC.1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg. 2006; 10:1199-1210; discussion 1210-1191
4. Zhou G, Niu L, Chiu D, He L, Xu K. Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-alpha and TSGF after cryosurgery in pancreatic cancer patients. Biotechnol Lett. 2012; 34: 1235-1241
5. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. MicroRNA expression and function in cancer. Trends Mol Med. 2006; 12:580-587
6. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007; 302:1-12
7. Cai X, Cullen BR. The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA. 2007; 13: 313-316
8. Keniry A, Oxley D, Monnier P, Kyba M, Dandolo L. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol. 2012; 14:659-665
9. Raveh E, Matouk IJ, Gilon M, Hochberg A. The H19 Long non-coding RNA in cancer initiation, progression and metastasis-a proposed unifying theory. Mol Cancer. 2015; 14:184
10. Matouk IJ, Halle D, Raveh E, Gilon M, Sorin V, Hochberg A. The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision. Oncotarget. 2016; 7:3748-65. doi: 10.18632/oncotarget.6387
11. Muller S, Raulefs S, Bruns P, Afonso-Grunz F, Plotner A. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer. Mol Cancer.2015;14: 94
12. Rubin SM, Gall AL, Zheng N, Pavletich NP. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell.2005; 123: 1093-1106
13. Shang Y, Feng B, Zhou L, Ren G, Zhang Z, Fan X, Sun Y, Luo G, Liang J, Wu K, Nie Y, Fan D. The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer. Oncotarget. 2016; 7:538-49. doi: 10.18632/oncotarget.6374
14. Gregory PA, Bracken CP, Bert AG, Goodall GJ. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle. 2008; 7:3112-3118
15. Li A, Omura N, Hong SM, Vincent A, Walter K. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res. 2010; 70:5226-5237
16. Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J. 2011; 30:770-782
17. Shah PP, Lockwood WW, Saurabh K, Kurlawala Z, Shannon SP. Ubiquilin1 represses migration and epithelialto-mesenchymal transition of human non-small cell lung cancer cells. Oncogene. 2015; 34:1709-1717
18. Chen Y, McGee J, Chen X, Doman TN, Gong X. Identification of druggable cancer driver genes amplified across TCGA datasets. PLoS One. 2014; 9:e98293
19. He D, Wang J, Zhang C, Shan B, Deng X. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in nonsmall cell lung cancer. Mol Cancer. 2015; 14:73
20. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002; 420:629-635
21. Tsang WP, Ng EK, Ng SS, Jin H, Yu J. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis.2010; 31: 350-358
22. Li H, Yu B, Li J, Su L, Yan M, Zhu Z, Liu B. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget. 2014; 5:2318-29. doi: 10.18632/oncotarget.1913
23. Shi Y, Wang Y, Luan W, Wang P, Tao T. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS One. 2014; 9:e86295
24. Zhang L, Yang F, Yuan JH, Yuan SX, Zhou WP. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis. 2013; 34:577-586
25. Ma C, Nong K, Zhu H, Wang W, Huang X. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumour Biol. 2014; 35:9163-9169
26. Kruger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 2006; 34:W451-454
27. Chu K, Boley KM, Moraes R, Barsky SH, Robertson FM. The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism. Oncotarget. 2013; 4:446-62. doi: 10.18632/oncotarget.872